In a significant advancement for prostate cancer research, a first-of-its kind study led by Emory researchers uncovered how the disease transforms ...

I must begin this story by emphasising the importance of periodic medical examinations to ensure that any illness is detected ...

Health technology company Royal Philips announced it received FDA 510 (k) clearance for its latest image-guided navigation ...

Discover how CRISPR gene editing is creating personalized cancer therapies, enhancing immunotherapy, and offering new hope ...

Weill Cancer Hub West will harness genomics, big data, AI, and machine learning to counter California’s 20 new cancer cases ...

CAN-2409 is an investigational, off-the-shelf, replication-defective adenovirus engineered to deliver the herpes simplex virus thymidine kinase (HSV-tk) gene to tumor cells. When administered with a ...

With regard to the choice of bone-protecting agent, denosumab (Xgeva) improved bone density and reduced fracture risk in a ...

A stage-four cancer diagnosis once sounded like the end of the road – after all, there is no stage five. When Joe Biden’s ...

Hyundai ADM Bio said Monday that it is working on a new drug, Penetrium, which is intended to help enhance the efficiency of ...

Research confirms that many men with nonmetastatic prostate cancer will not die of their disease once they received recommended treatment.

A phase 2 trial shows promising safety results for carotuximab in treating advanced prostate cancer, offering hope for ...

Prostate cancer is one of the most common cancers in men in the United States. While one in nine men will be diagnosed with ...